193 related articles for article (PubMed ID: 19508713)
21. Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells.
Liu H; Pan Z; Li A; Fu S; Lei Y; Sun H; Wu M; Zhou W
Cell Mol Immunol; 2008 Oct; 5(5):373-8. PubMed ID: 18954561
[TBL] [Abstract][Full Text] [Related]
22. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases.
Russell HV; Hicks J; Okcu MF; Nuchtern JG
J Pediatr Surg; 2004 Oct; 39(10):1506-11. PubMed ID: 15486895
[TBL] [Abstract][Full Text] [Related]
23. Coexpression of CXCR4 and MMP9 predicts lung metastasis and poor prognosis in resected osteosarcoma.
Ren Z; Liang S; Yang J; Han X; Shan L; Wang B; Mu T; Zhang Y; Yang X; Xiong S; Wang G
Tumour Biol; 2016 Apr; 37(4):5089-96. PubMed ID: 26546437
[TBL] [Abstract][Full Text] [Related]
24. CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases.
Yopp AC; Shia J; Butte JM; Allen PJ; Fong Y; Jarnagin WR; DeMatteo RP; D'Angelica MI
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S339-46. PubMed ID: 21584832
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical expression of stromal cell-derived factor-1 (SDF-1) and CXCR4 ligand receptor system in hepatocellular carcinoma.
Li W; Gomez E; Zhang Z
J Exp Clin Cancer Res; 2007 Dec; 26(4):527-33. PubMed ID: 18365549
[TBL] [Abstract][Full Text] [Related]
26. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
27. Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression.
Jiang YP; Wu XH; Shi B; Wu WX; Yin GR
Gynecol Oncol; 2006 Oct; 103(1):226-33. PubMed ID: 16631235
[TBL] [Abstract][Full Text] [Related]
28. Chemokine receptors in advanced breast cancer: differential expression in metastatic disease sites with diagnostic and therapeutic implications.
Cabioglu N; Sahin AA; Morandi P; Meric-Bernstam F; Islam R; Lin HY; Bucana CD; Gonzalez-Angulo AM; Hortobagyi GN; Cristofanilli M
Ann Oncol; 2009 Jun; 20(6):1013-9. PubMed ID: 19237480
[TBL] [Abstract][Full Text] [Related]
29. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
Hou KZ; Fu ZQ; Gong H
World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
[TBL] [Abstract][Full Text] [Related]
30. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.
Lin F; Zheng SE; Shen Z; Tang LN; Chen P; Sun YJ; Zhao H; Yao Y
Med Oncol; 2011 Jun; 28(2):649-53. PubMed ID: 20349215
[TBL] [Abstract][Full Text] [Related]
31. CXCR4 and VEGF expression in the primary site and the metastatic site of human osteosarcoma: analysis within a group of patients, all of whom developed lung metastasis.
Oda Y; Yamamoto H; Tamiya S; Matsuda S; Tanaka K; Yokoyama R; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2006 May; 19(5):738-45. PubMed ID: 16528367
[TBL] [Abstract][Full Text] [Related]
32. Prognostic and Predictive Role of CXC Chemokine Receptor 4 in Metastatic Colorectal Cancer Patients.
Ottaiano A; Scala S; Normanno N; Botti G; Tatangelo F; Di Mauro A; Capozzi M; Facchini S; Tafuto S; Nasti G
Appl Immunohistochem Mol Morphol; 2020; 28(10):755-760. PubMed ID: 31985548
[TBL] [Abstract][Full Text] [Related]
33. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
[TBL] [Abstract][Full Text] [Related]
34. Potential role of HER-2; in primary breast tumor with bone metastasis.
Kim R; Arihiro K; Emi M; Tanabe K; Osaki A
Oncol Rep; 2006 Jun; 15(6):1477-84. PubMed ID: 16685382
[TBL] [Abstract][Full Text] [Related]
35. Chemokine receptor CCR7 expression predicts poor outcome in uveal melanoma and relates to liver metastasis whereas expression of CXCR4 is not of clinical relevance.
van den Bosch T; Koopmans AE; Vaarwater J; van den Berg M; de Klein A; Verdijk RM
Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7354-61. PubMed ID: 24052640
[TBL] [Abstract][Full Text] [Related]
36. Regional expression of CXCL12/CXCR4 in liver and hepatocellular carcinoma and cell-cycle variation during in vitro differentiation.
Shibuta K; Mori M; Shimoda K; Inoue H; Mitra P; Barnard GF
Jpn J Cancer Res; 2002 Jul; 93(7):789-97. PubMed ID: 12149145
[TBL] [Abstract][Full Text] [Related]
37. FRZB up-regulated in hepatocellular carcinoma bone metastasis.
Huang J; Hu W; Lin X; Wang X; Jin K
Int J Clin Exp Pathol; 2015; 8(10):13353-9. PubMed ID: 26722540
[TBL] [Abstract][Full Text] [Related]
38. Bone metastases and hepatocellular carcinoma: some food for thought.
Lasagna A; Cuzzocrea F; Maccario G; Mahagna A; Sacchi P; U Mondelli M
Future Oncol; 2021 Oct; 17(29):3777-3780. PubMed ID: 34313153
[No Abstract] [Full Text] [Related]
39. Vascular CXCR4 Expression Promotes Vessel Sprouting and Sensitivity to Sorafenib Treatment in Hepatocellular Carcinoma.
Xu J; Liang J; Meng YM; Yan J; Yu XJ; Liu CQ; Xu L; Zhuang SM; Zheng L
Clin Cancer Res; 2017 Aug; 23(15):4482-4492. PubMed ID: 28223275
[No Abstract] [Full Text] [Related]
40. Pre-metastatic niche triggers SDF-1/CXCR4 axis and promotes organ colonisation by hepatocellular circulating tumour cells via downregulation of Prrx1.
Tang Y; Lu Y; Chen Y; Luo L; Cai L; Peng B; Huang W; Liao H; Zhao L; Pan M
J Exp Clin Cancer Res; 2019 Nov; 38(1):473. PubMed ID: 31752959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
